Published in AMIA Annu Symp Proc on January 01, 2005
What can natural language processing do for clinical decision support? J Biomed Inform (2009) 4.51
MediClass: A system for detecting and classifying encounter-based clinical events in any electronic medical record. J Am Med Inform Assoc (2005) 2.45
Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc (2007) 1.14
Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. Drug Saf (2017) 0.83
An evaluation of a natural language processing tool for identifying and encoding allergy information in emergency department clinical notes. AMIA Annu Symp Proc (2014) 0.77
The Unified Medical Language System: an informatics research collaboration. J Am Med Inform Assoc (1998) 14.64
Unlocking clinical data from narrative reports: a study of natural language processing. Ann Intern Med (1995) 14.15
Natural language processing and the representation of clinical data. J Am Med Inform Assoc (1995) 13.20
The HL7 Clinical Document Architecture. J Am Med Inform Assoc (2001) 7.42
The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv (1995) 6.73
Automatic detection of acute bacterial pneumonia from chest X-ray reports. J Am Med Inform Assoc (2000) 5.60
Automating a severity score guideline for community-acquired pneumonia employing medical language processing of discharge summaries. Proc AMIA Symp (1999) 3.77
Identification of suspected tuberculosis patients based on natural language processing of chest radiograph reports. Proc AMIA Annu Fall Symp (1996) 3.74
Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc (2001) 2.98
MediClass: A system for detecting and classifying encounter-based clinical events in any electronic medical record. J Am Med Inform Assoc (2005) 2.45
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
Coding neuroradiology reports for the Northern Manhattan Stroke Study: a comparison of natural language processing and manual review. Comput Biomed Res (2000) 1.93
Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc (2004) 1.68
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med (2003) 3.49
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr (2013) 2.86
Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis (2002) 2.64
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine (2011) 1.70
The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics (2011) 1.60
Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med (2014) 1.59
Safety of the yellow Fever vaccine: a retrospective study. J Travel Med (2013) 1.38
Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol (2013) 1.24
Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics (2011) 1.20
H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med (2011) 1.12
Screening HMO women overdue for both mammograms and pap tests. Prev Med (2002) 1.07
Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol (2013) 1.07
Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis (2004) 1.04
Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol (2013) 1.04
Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine (2009) 1.04
Screening rarely screened women: time-to-service and 24-month outcomes of tailored interventions. Prev Med (2003) 0.98
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. Vaccine (2012) 0.96
Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics (2012) 0.96
Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol (2013) 0.93
Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states. J Addict Dis (2009) 0.92
Factors predicting completion of the human papillomavirus vaccine series. J Adolesc Health (2012) 0.87
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine (2013) 0.86
Automating quality measurement: a system for scalable, comprehensive, and routine care quality assessment. AMIA Annu Symp Proc (2009) 0.86
Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med (2010) 0.85
Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm J (2013) 0.85
The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. Am J Obstet Gynecol (2011) 0.84
Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf (2014) 0.84
Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillance. Sex Transm Dis (2008) 0.83
Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine. J Infect Dis (2013) 0.83
Consistency of influenza A virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR. J Clin Microbiol (2013) 0.82
Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med (2013) 0.82
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infect Dis (2009) 0.82
Impact of intensified dental care on outcomes in human immunodeficiency virus infection. AIDS Patient Care STDS (2002) 0.81
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine (2005) 0.80
Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol (2012) 0.80
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis (2012) 0.79
Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf (2007) 0.79
Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J (2006) 0.79
Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine (2009) 0.78
Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. Vaccine (2011) 0.77
Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatr (2005) 0.77
Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine (2010) 0.76
Impact on CDC Guideline Compliance After Incorporating Pharmacy in a Pneumococcal Vaccination Screening Process. Hosp Pharm (2016) 0.75
Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. Clin Infect Dis (2005) 0.75
Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwest. Sex Transm Dis (2014) 0.75
Positive Predictive Value of ICD-9 Code for Herpes Zoster Among Children During the Varicella Vaccine Era. Pediatr Infect Dis J (2016) 0.75